http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#Head
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#assertion
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#provenance
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#pubinfo
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#assertion
http://purl.obolibrary.org/obo/MONDO_0001156
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/MONDO_0001156
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://go.drugbank.com/drugs/DB00334
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association
http://www.w3.org/2000/01/rdf-schema#label
Antipsychotics have been found to reduce BPD symptoms including aripiprazole (mean daily dose: 15 mg); ziprasidone (mean daily dose: 20 to 80 mg), olanzapine (mean daily dose: 5 to 9 mg, daily dose range 5 to 20 mg), haloperidol (mean daily dose 5 mg, daily dose range 4 to 16 mg), Quetiapine XL (at a daily dose of 150 mg). The empirically use of antipsychotics in patients with BPD are considered as off-label use.
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association
https://w3id.org/biolink/vocab/has_population_context
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#cohort
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association
https://w3id.org/biolink/vocab/publications
https://pubmed.ncbi.nlm.nih.gov/28825781/
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/OffLabelIndication
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#cohort
http://www.w3.org/2000/01/rdf-schema#label
Adults
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#cohort
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Cohort
https://go.drugbank.com/drugs/DB00334
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#provenance
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#pubinfo
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#sig
http://purl.org/nanopub/x/hasSignature
brKON5IvjKt8Rl0LVnjpdLlRh+8G8Qs9R/rKY/+DxfzyON8HyVhEr2TP7nVwoJzhJVL/77+37mjz2qRkOKmJkD+Que8eigUrxSlBekABAx7/PIf3nzWjBNalmZpIy9R6fETb9SQZyZu/pEiAjm0wOrWyqPElxmakFS3ikUYSTd0=
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU
http://purl.org/dc/terms/created
2021-05-28T22:37:01.486+02:00
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs